Jim Cramer: This Health Care Stock Has Been 'Horrendous'

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ:RXRX) has been “horrendous” and he does not like to recommend horrendous stocks.On the earnings front, Recursion Pharmaceuticals posted weaker-than-expected results for the third quarter on Nov. 5. The company reported a quarterly loss of 36 cents per share, compared to market estimates of a loss of 31 cents per share. The company reported quarterly sales of $5.175 million, which missed the analyst consensu ...